Associations of Depression, Anxiety, Worry, Perceived Stress, and Loneliness Prior to Infection With Risk of Post-COVID-19 ConditionsArticle Published on 2022-11-012022-11-16 Journal: JAMA Psychiatry [Category] SARS, 유전자 메커니즘, [키워드] 95% CI adjusted age Anxiety baseline characterized Comorbidities condition COVID COVID-19 COVID-19 symptom COVID-19-related symptom Depression determine distress female Final Follow-up Future Health health care workers highest impairment increased risk individual Infection loneliness long-lasting lowest mechanism Nurse outcome pandemic participant Participants Perceived Perceived stress positive Postinfection prospective cohort study Psychological distress questionnaire Questionnaires reported returned risk risk factor SARS-COV-2 infection SARS-CoV-2 test sociodemographic factors Symptoms the mean these symptom used data were measured Worry [DOI] 10.1001/jamapsychiatry.2022.2640 PMC 바로가기
Protection by Vaccines and Previous Infection Against the Omicron Variant of Severe Acute Respiratory Syndrome Coronavirus 2Article Published on 2022-10-172022-11-16 Journal: The Journal of Infectious Diseases [Category] COVID19(2023년), SARS, 변종, [키워드] 95% CI 95% confidence interval acute respiratory syndrome Admission Against booster coronavirus coronavirus 2 COVID-19 Cox proportional hazard Czech Republic declined Delta Effectiveness evade Hospitalization Immunity Infection infections intensive care Logistic regression need for oxygen Odds ratio omicron Omicron variant outcome oxygen Postinfection postinfection immunity protection reached recent respiratory risk SARS-CoV-2 therapy vaccination Vaccine vaccine effectiveness variant [DOI] 10.1093/infdis/jiac161 PMC 바로가기
Estimated Protection of Prior SARS-CoV-2 Infection Against Reinfection With the Omicron Variant Among Messenger RNA-Vaccinated and Nonvaccinated Individuals in Quebec, CanadaArticle Published on 2022-10-032022-11-16 Journal: JAMA Network Open [Category] COVID19(2023년), SARS, 변종, 치료기술, [키워드] 95% CI adjusted Against age Care case-control study conducted dose doses Estimated female genomic greater Health Heterologous Hospitalization individual individuals Infection laboratory-confirmed laboratory-confirmed SARS-CoV-2 infection messenger Messenger RNA mRNA mRNA vaccination mRNA vaccine Odds ratio Older omicron outcome participant Participants phylogenetically Postinfection Prevent protection provided quantification Quebec, Canada reduction Reinfection risk risk reduction SARS-CoV-2 SARS-COV-2 infection SARS-CoV-2 variant severity Sex significantly higher stratified Surveillance tested vaccinated individual vaccination Vaccine vaccine dose vaccine strain variant [DOI] 10.1001/jamanetworkopen.2022.36670 PMC 바로가기
Antiviral efficacy of selective estrogen receptor modulators against SARS-CoV-2 infection in vitro and in vivo reveals bazedoxifene acetate as an entry inhibitor시험관 내 및 생체 내에서 SARS-CoV-2 감염에 대한 선택적 에스트로겐 수용체 조절제의 항바이러스 효능은 진입 억제제로서 바제독시펜 아세테이트를 나타냅니다Article Published on 2022-10-012022-09-11 Journal: Journal of medical virology [Category] COVID19(2023년), SARS, 변종, 신약개발, 치료제, [키워드] Acetate acute respiratory syndrome acute respiratory syndrome coronavirus acute respiratory syndrome coronavirus 2 anti-SARS-CoV-2 antiviral efficacy Bazedoxifene bazedoxifene acetate candidate cholesterol cholesterol distribution citrate clinical Clomifene Clomifene citrate contagious coronavirus Coronaviruses Critical delta variant distribution drugs Effect Efficacy endosome acidification Estrogen estrogen receptor evaluated exhibited expression hamster hamsters human cell lines humans identify in vitro in vivo infect Infection information inhibited inhibitor interleukin-6 offer omicron Omicron variant pathogenic variant penetration Postinfection pseudovirus pseudoviruses pulmonary viral reduced reveal SARS-CoV SARS-CoV-2 SARS-COV-2 infection selective selective estrogen receptor modulator severe acute respiratory syndrome Coronavirus severe acute respiratory syndrome coronavirus 2 Tamoxifen toremifene toremifene citrate variant Vero E6 Vero E6 cell VERO E6 cells weight loss [DOI] 10.1002/jmv.27951 PMC 바로가기 [Article Type] Article
Antibody response three months after SARS-CoV-2 infectionSARS-CoV-2 감염 3개월 후 항체 반응Article Published on 2022-10-012022-09-12 Journal: Journal of medical virology [Category] COVID19(2023년), MERS, SARS, 진단, [키워드] acute respiratory syndrome anti-SARS-CoV-2 antibody antibody level Antigen applied coated with collected coronavirus Coronavirus disease-19 cough COVID-19 COVID-19 infection determine ELISA fatigue Hospitalized IgG immune immune responses Immunoglobulin individual individuals Infection Insomnia joint loss of taste Pain pandemic positive Postinfection Prevent problem public health Reinfection Research SARS Coronavirus SARS-CoV-2 SARS-CoV-2 antibodies SARS-COV-2 infection serum antibody serum sample state Symptom Tarsus tested those with comorbidities threshold virus virus classification weakness [DOI] 10.1002/jmv.27909 PMC 바로가기 [Article Type] Article
A single-administration therapeutic interfering particle reduces SARS-CoV-2 viral shedding and pathogenesis in hamstersArticle Published on 2022-09-272022-11-15 Journal: Proceedings of the National Academy of Sciences of [Category] SARS, 변종, 치료기술, 치료제, [키워드] acute respiratory syndrome Administered Antiviral effect coronavirus COVID-19 pandemic delta variant Detection limit disease dose effective Efficacy exhibited hamster hamsters highest Infectious virus Inflammatory cytokines Intervention intranasally intrinsically limit Lipid nanoparticle Lower mucosa nasal Particle Pathogenesis Postinfection Prevent reduce reduced reported respiratory tissue respiratory virus SARS-CoV-2 SARS-CoV-2 replication SARS-CoV-2 transmission SARS-CoV-2 viral shedding severe disease severe lung pathology significantly lower suppress tested therapeutic therapeutic interfering particles TIP tissue Transmissibility Transmission uninfected variants viral loads viral replication while [DOI] 10.1073/pnas.2204624119 PMC 바로가기
The Omicron Variant BA.1.1 Presents a Lower Pathogenicity than B.1 D614G and Delta Variants in a Feline Model of SARS-CoV-2 InfectionArticle Published on 2022-09-142022-11-15 Journal: Journal of Virology [Category] SARS, 변종, 치료기술, [키워드] addition B.1 B.1.1.529 B.1.617.2 body temperature cats clinical COVID-19 D614G death Delta delta variant disease severity distribution effective Evidence evidenced histologic Hospitalization immunization immunofluorescence increased risk Infection infections Infectious virus Inflammation inoculated less lethargic log Lower lung Lung pathology Mild Model mutated nasal nasal turbinate observation omicron Pathogenesis pathogenic pathogenicity Pneumonia Postinfection present reduced remained Replication SARS-CoV-2 SARS-CoV-2 D614G SARS-CoV-2 variant secretion significant increase South Africa Spread staining suggested susceptible TCID tissue tissue tropism variant variant of concern variants Viral load viral replication Viral RNA viral titer Viral variants Virological virulence virus [DOI] 10.1128/jvi.00961-22 PMC 바로가기
Boosting maternal and neonatal humoral immunity following SARS-CoV-2 infection using a single messenger RNA vaccine dose단일 메신저 RNA 백신 용량을 사용하여 SARS-CoV-2 감염 후 산모 및 신생아 체액성 면역 강화Article Published on 2022-09-012022-09-11 Journal: American journal of obstetrics and gynecology [Category] COVID19(2023년), MERS, SARS, 진단, 치료기술, [키워드] Affect analyzed anti SARS-CoV-2 antibody anti-SARS-CoV-2 antibody antibody antibody levels approach BNT162b2 booster dose boosting vaccine dose Case-control case-control study collected consecutive sample convalescent Cord blood COVID-19 COVID-19 vaccination determined by dose during pregnancy Effect first trimester group Guidance Humoral immunity increase in Infection Jerusalem Messenger RNA Mild symptom mild symptoms moderate mother naïve Neonatal Newborn outcomes pandemic parturient patients polymerase chain polymerase chain reaction Postinfection postinfection vaccine Pregnancy proportion Protective reported robust SARS-CoV-2 SARS-COV-2 infection second trimester selected serum sample serum samples side Side effects single booster dose single dose Stage study groups tested Umbilical cord umbilical cord blood umbilical cords undetectable vaccination Vaccine vaccine dose vaccine during. was determined [DOI] 10.1016/j.ajog.2022.04.010 PMC 바로가기 [Article Type] Article
SARS-CoV-2 Convalescent Sera Binding and Neutralizing Antibody Concentrations Compared with COVID-19 Vaccine Efficacy Estimates against Symptomatic InfectionArticle Published on 2022-08-312022-11-15 Journal: Microbiology Spectrum [Category] COVID19(2023년), SARS, 변종, 진단, 치료기술, [키워드] anti-SARS-CoV-2 anti-SARS-CoV-2 antibody antibodies antibody antibody concentration Antigen benefit binding antibody booster dose circulating collected Concentration Correlate of protection correlated correlation COVID-19 COVID-19 vaccine detectable detectable anti-SARS-CoV-2 antibodies Efficacy estimate Evidence exceeded Guidance IgG immune Immunity include Infection Neutralizing Neutralizing antibodies new SARS-CoV-2 observation Postinfection postvaccination Prevent proportion protection Protective provide public health Quantitative recommendation SARS-CoV-2 SARS-COV-2 infection serum specimen standardized. study population Support symptomatic symptomatic infection vaccination variant virus strains with COVID-19 [DOI] 10.1128/spectrum.01247-22 PMC 바로가기
Decreased Efficiency of Neutralizing Antibodies from Previously Infected or Vaccinated Individuals against the B.1.617.2 (Delta) SARS-CoV-2 VariantArticle Published on 2022-08-312022-11-15 Journal: Microbiology Spectrum [Category] COVID19(2023년), SARS, 변종, 진단, [키워드] acute respiratory syndrome adaptive analyzed antibody antibody concentration arise B cell B.1.617.2 binding binding antibodies binding antibody binding antibody unit blood sample collected Concentration coronavirus correlated Decreased Delta delta variant greater HCW HCWs Health care worker immune responses Immunity immunoassay individual Infection injection interquartile range IQR less maintain median neutralization neutralize Neutralizing Neutralizing antibodies neutralizing antibody Neutralizing antibody response Neutralizing antibody titer neutralizing capacity Postinfection protection Protective question recent reduction in Registered required responses SARS-CoV-2 severe disease T cell the SARS-CoV-2 Transmissibility two virus strains vaccination Vaccine variants were measured [DOI] 10.1128/spectrum.02706-21 PMC 바로가기